发明名称 DRUG DEVELOPMENT TARGET PROTEIN AND TARGET GENE, AND METHOD OF SCREENING
摘要 <p>A novel drug development target protein and gene, and, using these, means for developing a novel pharmaceutical. In particular, there are provided an NCS protein and a gene therefor; a method of screening a drug (for example, anti-central neurologic disease agent); a regulator of diseases (for example, central neurologic disease); a process for producing drug derivatives; a complex containing a drug and an NCS protein, and a process for producing the same; a kit including a drug or its salt; a method of determining the development or development risk of given disease, a method of determining the sensitivity to drugs, and a determination kit for use in the methods; etc. Further, there is provided a compound, or its salt, capable of binding to NCS proteins, represented by the following formula (I), and provided a therapeutic or preventive agent for dementia comprising the compound of the formula (I) or pharmaceutically acceptable salt thereof as an active ingredient. (wherein R1-R8 represent hydrogen atoms, etc.)</p>
申请公布号 WO2006043710(A1) 申请公布日期 2006.04.27
申请号 WO2005JP19645 申请日期 2005.10.19
申请人 REVERSE PROTEOMICS RESEARCH INSTITUTE CO., LTD.;YAMAUCHI, TADAKAZU;SUEOKA, HIDEAKI;TSUCHIYA, KOUICHI;MURAYAMA, KATSUHISA;HORIUCHI, KEN;KOMIYA, KAZUO;KITO, MORIKAZU;TSUTSUMI, TAKESHI;ISONO, YUKO;SUWA, YORIMASA 发明人 YAMAUCHI, TADAKAZU;SUEOKA, HIDEAKI;TSUCHIYA, KOUICHI;MURAYAMA, KATSUHISA;HORIUCHI, KEN;KOMIYA, KAZUO;KITO, MORIKAZU;TSUTSUMI, TAKESHI;ISONO, YUKO;SUWA, YORIMASA
分类号 A61K31/40;C07C211/27;A61K45/00;A61P25/00;A61P25/28;C07K14/47;C12N1/15;C12N1/19;C12N15/09 主分类号 A61K31/40
代理机构 代理人
主权项
地址